Imported Disease Annotations - CTDObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CIBAR2 | Human | Crohn's disease | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:17435756 | |
|
Imported Disease Annotations - CTDObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CIBAR2 | Human | Crohn's disease | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:17435756 | |
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
2. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:8889548 | PMID:12477932 | PMID:18580884 | PMID:19262523 | PMID:21472827 | PMID:21873635 | PMID:27528616 | PMID:28700943 | PMID:32707033 | PMID:33961781 | PMID:36736316 |
CIBAR2 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cibar2 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cibar2 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cibar2 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CIBAR2 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CIBAR2 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cibar2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CIBAR2 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CIBAR2 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cibar2 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in CIBAR2
12 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 16q23.1-24.3(chr16:78816291-90081985)x3 | copy number gain | See cases [RCV000050840] | Chr16:78816291..90081985 [GRCh38] Chr16:78850188..90148393 [GRCh37] Chr16:77407689..88675894 [NCBI36] Chr16:16q23.1-24.3 |
pathogenic |
GRCh38/hg38 16q23.3-24.2(chr16:83878992-87223838)x1 | copy number loss | See cases [RCV000051122] | Chr16:83878992..87223838 [GRCh38] Chr16:83912597..87257444 [GRCh37] Chr16:82470098..85814945 [NCBI36] Chr16:16q23.3-24.2 |
pathogenic |
GRCh38/hg38 16q22.1-24.3(chr16:70514631-90081985)x3 | copy number gain | See cases [RCV000052422] | Chr16:70514631..90081985 [GRCh38] Chr16:70548534..90148393 [GRCh37] Chr16:69106035..88675894 [NCBI36] Chr16:16q22.1-24.3 |
pathogenic |
GRCh38/hg38 16q21-24.3(chr16:65313395-90081985)x3 | copy number gain | See cases [RCV000052421] | Chr16:65313395..90081985 [GRCh38] Chr16:65347298..90148393 [GRCh37] Chr16:63904799..88675894 [NCBI36] Chr16:16q21-24.3 |
pathogenic |
GRCh38/hg38 16q23.3-24.1(chr16:84081930-85474903)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052019]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052019]|See cases [RCV000052019] | Chr16:84081930..85474903 [GRCh38] Chr16:84115535..85508509 [GRCh37] Chr16:82673036..84066010 [NCBI36] Chr16:16q23.3-24.1 |
uncertain significance |
GRCh38/hg38 16q23.1-24.3(chr16:76873569-90081985)x3 | copy number gain | See cases [RCV000052423] | Chr16:76873569..90081985 [GRCh38] Chr16:76907466..90148393 [GRCh37] Chr16:75464967..88675894 [NCBI36] Chr16:16q23.1-24.3 |
pathogenic |
GRCh38/hg38 16q23.3-24.3(chr16:82173150-90081985)x3 | copy number gain | See cases [RCV000052424] | Chr16:82173150..90081985 [GRCh38] Chr16:82206755..90148393 [GRCh37] Chr16:80764256..88675894 [NCBI36] Chr16:16q23.3-24.3 |
pathogenic |
GRCh38/hg38 16q24.1-24.3(chr16:84707538-90081985)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052425]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052425]|See cases [RCV000052425] | Chr16:84707538..90081985 [GRCh38] Chr16:84741144..90148393 [GRCh37] Chr16:83298645..88675894 [NCBI36] Chr16:16q24.1-24.3 |
pathogenic |
GRCh38/hg38 16q23.1-24.2(chr16:78704275-87819342)x1 | copy number loss | See cases [RCV000053359] | Chr16:78704275..87819342 [GRCh38] Chr16:78738172..87852948 [GRCh37] Chr16:77295673..86410449 [NCBI36] Chr16:16q23.1-24.2 |
pathogenic |
GRCh38/hg38 16q23.3-24.1(chr16:81753762-85714791)x1 | copy number loss | See cases [RCV000053360] | Chr16:81753762..85714791 [GRCh38] Chr16:81787367..85748397 [GRCh37] Chr16:80344868..84305898 [NCBI36] Chr16:16q23.3-24.1 |
pathogenic |
NM_198491.2(FAM92B):c.376G>A (p.Glu126Lys) | single nucleotide variant | Malignant melanoma [RCV000071263] | Chr16:85107896 [GRCh38] Chr16:85141502 [GRCh37] Chr16:83699003 [NCBI36] Chr16:16q24.1 |
not provided |
GRCh38/hg38 16q23.3-24.3(chr16:83988570-90081985)x3 | copy number gain | See cases [RCV000135659] | Chr16:83988570..90081985 [GRCh38] Chr16:84022175..90148393 [GRCh37] Chr16:82579676..88675894 [NCBI36] Chr16:16q23.3-24.3 |
likely pathogenic |
GRCh38/hg38 16q23.3-24.1(chr16:83687650-86073240)x1 | copy number loss | See cases [RCV000136504] | Chr16:83687650..86073240 [GRCh38] Chr16:83721255..86106846 [GRCh37] Chr16:82278756..84664347 [NCBI36] Chr16:16q23.3-24.1 |
pathogenic |
GRCh38/hg38 16q23.2-24.3(chr16:80946659-90081985)x3 | copy number gain | See cases [RCV000136898] | Chr16:80946659..90081985 [GRCh38] Chr16:80980556..90148393 [GRCh37] Chr16:79538057..88675894 [NCBI36] Chr16:16q23.2-24.3 |
pathogenic|likely pathogenic |
GRCh38/hg38 16q22.1-24.3(chr16:70749398-90096995)x3 | copy number gain | See cases [RCV000137495] | Chr16:70749398..90096995 [GRCh38] Chr16:70783301..90163403 [GRCh37] Chr16:69340802..88690904 [NCBI36] Chr16:16q22.1-24.3 |
pathogenic |
GRCh38/hg38 16q23.3-24.3(chr16:83478453-89932910)x3 | copy number gain | See cases [RCV000137980] | Chr16:83478453..89932910 [GRCh38] Chr16:83512058..89999318 [GRCh37] Chr16:82069559..88526819 [NCBI36] Chr16:16q23.3-24.3 |
likely pathogenic |
GRCh38/hg38 16q24.1(chr16:85026633-85843419)x3 | copy number gain | See cases [RCV000138715] | Chr16:85026633..85843419 [GRCh38] Chr16:85060239..85877025 [GRCh37] Chr16:83617740..84434526 [NCBI36] Chr16:16q24.1 |
likely benign |
GRCh38/hg38 16q21-24.3(chr16:65511483-90096995)x3 | copy number gain | See cases [RCV000139426] | Chr16:65511483..90096995 [GRCh38] Chr16:65545386..90163403 [GRCh37] Chr16:64102887..88690904 [NCBI36] Chr16:16q21-24.3 |
pathogenic |
GRCh38/hg38 16q23.1-24.3(chr16:75377981-90081992)x3 | copy number gain | See cases [RCV000139302] | Chr16:75377981..90081992 [GRCh38] Chr16:75411879..90148400 [GRCh37] Chr16:73969380..88675901 [NCBI36] Chr16:16q23.1-24.3 |
pathogenic |
GRCh38/hg38 16q23.2-24.3(chr16:80717291-90096662)x3 | copy number gain | See cases [RCV000141128] | Chr16:80717291..90096662 [GRCh38] Chr16:80751188..90163070 [GRCh37] Chr16:79308689..88690571 [NCBI36] Chr16:16q23.2-24.3 |
pathogenic |
GRCh38/hg38 16q23.1-24.3(chr16:76336203-90088654)x3 | copy number gain | See cases [RCV000141700] | Chr16:76336203..90088654 [GRCh38] Chr16:76370100..90155062 [GRCh37] Chr16:74927601..88682563 [NCBI36] Chr16:16q23.1-24.3 |
pathogenic |
GRCh38/hg38 16q23.2-24.3(chr16:80067315-90057871)x3 | copy number gain | See cases [RCV000142698] | Chr16:80067315..90057871 [GRCh38] Chr16:80101212..90124279 [GRCh37] Chr16:78658713..88651780 [NCBI36] Chr16:16q23.2-24.3 |
pathogenic |
GRCh38/hg38 16q21-24.3(chr16:64389378-90081985)x3 | copy number gain | See cases [RCV000142578] | Chr16:64389378..90081985 [GRCh38] Chr16:64423281..90148393 [GRCh37] Chr16:62980782..88675894 [NCBI36] Chr16:16q21-24.3 |
pathogenic|likely pathogenic |
GRCh38/hg38 16q12.2-24.3(chr16:52899183-90088654)x3 | copy number gain | See cases [RCV000143425] | Chr16:52899183..90088654 [GRCh38] Chr16:52933095..90155062 [GRCh37] Chr16:51490596..88682563 [NCBI36] Chr16:16q12.2-24.3 |
pathogenic |
GRCh37/hg19 16q23.1-24.3(chr16:74872514-90274440)x3 | copy number gain | See cases [RCV000240108] | Chr16:74872514..90274440 [GRCh37] Chr16:16q23.1-24.3 |
pathogenic |
t(5;16)(p15.31;q23.1) | translocation | not provided [RCV000203391] | Chr5:1..8180513 [GRCh37] Chr16:76935310..90354753 [GRCh37] Chr5:5p15.33-15.31 Chr16:16q23.1-24.3 |
likely pathogenic |
GRCh37/hg19 16q23.3-24.1(chr16:83553094-86098013)x1 | copy number loss | See cases [RCV000203439] | Chr16:83553094..86098013 [GRCh37] Chr16:16q23.3-24.1 |
likely pathogenic |
GRCh37/hg19 16q11.2-24.3(chr16:46615804-90142285)x1 | copy number loss | Breast ductal adenocarcinoma [RCV000207138] | Chr16:46615804..90142285 [GRCh37] Chr16:16q11.2-24.3 |
uncertain significance |
GRCh37/hg19 16q22.2-24.3(chr16:72107834-90142285)x1 | copy number loss | Breast ductal adenocarcinoma [RCV000207182] | Chr16:72107834..90142285 [GRCh37] Chr16:16q22.2-24.3 |
uncertain significance |
Single allele | complex | Breast ductal adenocarcinoma [RCV000207314] | Chr16:56368689..90141355 [GRCh37] Chr16:16q12.2-24.3 |
uncertain significance |
GRCh37/hg19 16q11.2-24.3(chr16:46464488-90155062)x3 | copy number gain | See cases [RCV000446110] | Chr16:46464488..90155062 [GRCh37] Chr16:16q11.2-24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 | copy number gain | See cases [RCV000446684] | Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.2-q24.3(chr16:9273328-89548493)x3 | copy number gain | See cases [RCV000511622] | Chr16:9273328..89548493 [GRCh37] Chr16:16p13.2-q24.3 |
uncertain significance |
GRCh37/hg19 16q24.1(chr16:84885505-85656345)x3 | copy number gain | See cases [RCV000511679] | Chr16:84885505..85656345 [GRCh37] Chr16:16q24.1 |
uncertain significance |
GRCh37/hg19 16q24.1-24.3(chr16:84937273-89836905)x4 | copy number gain | See cases [RCV000511606] | Chr16:84937273..89836905 [GRCh37] Chr16:16q24.1-24.3 |
likely pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) | copy number gain | See cases [RCV000511296] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16q11.2-24.3(chr16:46497599-90354753)x1 | copy number loss | Poly (ADP-Ribose) polymerase inhibitor response [RCV000626429] | Chr16:46497599..90354753 [GRCh37] Chr16:16q11.2-24.3 |
drug response |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 | copy number gain | See cases [RCV000512138] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16q11.2-24.3(chr16:46455960-90354753)x1 | copy number loss | Poly (ADP-Ribose) polymerase inhibitor response [RCV000626435] | Chr16:46455960..90354753 [GRCh37] Chr16:16q11.2-24.3 |
drug response |
NM_198491.3(CIBAR2):c.782C>A (p.Ala261Glu) | single nucleotide variant | not specified [RCV004324063] | Chr16:85099318 [GRCh38] Chr16:85132924 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.905A>G (p.His302Arg) | single nucleotide variant | not specified [RCV004310392] | Chr16:85099195 [GRCh38] Chr16:85132801 [GRCh37] Chr16:16q24.1 |
uncertain significance |
GRCh37/hg19 16q13-24.3(chr16:57051473-89797669)x3 | copy number gain | See cases [RCV000512511] | Chr16:57051473..89797669 [GRCh37] Chr16:16q13-24.3 |
pathogenic |
GRCh37/hg19 16q23.3-24.3(chr16:83001540-90155062)x3 | copy number gain | See cases [RCV000512468] | Chr16:83001540..90155062 [GRCh37] Chr16:16q23.3-24.3 |
likely pathogenic |
GRCh37/hg19 16q24.1(chr16:84914217-85276861)x1 | copy number loss | not provided [RCV000683853] | Chr16:84914217..85276861 [GRCh37] Chr16:16q24.1 |
uncertain significance |
GRCh37/hg19 16q22.2-24.3(chr16:72515938-90155062)x3 | copy number gain | not provided [RCV000683831] | Chr16:72515938..90155062 [GRCh37] Chr16:16q22.2-24.3 |
pathogenic |
GRCh37/hg19 16q23.2-24.3(chr16:79400436-90155062)x3 | copy number gain | not provided [RCV000683845] | Chr16:79400436..90155062 [GRCh37] Chr16:16q23.2-24.3 |
pathogenic |
GRCh37/hg19 16q24.1-24.2(chr16:84872102-87678641) | copy number loss | Alveolar capillary dysplasia with pulmonary venous misalignment [RCV001004081] | Chr16:84872102..87678641 [GRCh37] Chr16:16q24.1-24.2 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 | copy number gain | not provided [RCV000738918] | Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 | copy number gain | not provided [RCV000738915] | Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 | copy number gain | not provided [RCV000738917] | Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NC_000016.10:g.(?_84593050)_(85516675_?)del | deletion | Schizophrenia [RCV000754198] | Chr16:84593050..85516675 [GRCh38] Chr16:16q24.1 |
likely pathogenic |
GRCh37/hg19 16q23.3-24.3(chr16:82761333-90055381) | copy number gain | not provided [RCV000767619] | Chr16:82761333..90055381 [GRCh37] Chr16:16q23.3-24.3 |
pathogenic |
GRCh37/hg19 16q24.1(chr16:84815936-86045285)x1 | copy number loss | not provided [RCV001006835] | Chr16:84815936..86045285 [GRCh37] Chr16:16q24.1 |
uncertain significance |
GRCh37/hg19 16q24.1(chr16:85103803-85242940)x3 | copy number gain | not provided [RCV000847098] | Chr16:85103803..85242940 [GRCh37] Chr16:16q24.1 |
uncertain significance |
GRCh37/hg19 16q24.1(chr16:85038804-85876297)x3 | copy number gain | not provided [RCV000847805] | Chr16:85038804..85876297 [GRCh37] Chr16:16q24.1 |
uncertain significance |
GRCh37/hg19 16q21-24.3(chr16:61524229-90155062)x3 | copy number gain | not provided [RCV001249359] | Chr16:61524229..90155062 [GRCh37] Chr16:16q21-24.3 |
not provided |
GRCh37/hg19 16q24.1(chr16:85103803-85242940)x3 | copy number gain | not provided [RCV000846321] | Chr16:85103803..85242940 [GRCh37] Chr16:16q24.1 |
uncertain significance |
Single allele | deletion | Alveolar capillary dysplasia with pulmonary venous misalignment [RCV001251455] | Chr16:83931797..86285776 [GRCh37] Chr16:16q23.3-24.1 |
likely pathogenic |
GRCh37/hg19 16q23.3-24.1(chr16:83866931-85276940)x3 | copy number gain | not provided [RCV001258657] | Chr16:83866931..85276940 [GRCh37] Chr16:16q23.3-24.1 |
uncertain significance |
GRCh37/hg19 16q23.2-24.3(chr16:80386595-90163348)x3 | copy number gain | not provided [RCV001795551] | Chr16:80386595..90163348 [GRCh37] Chr16:16q23.2-24.3 |
pathogenic |
GRCh37/hg19 16q23.3-24.1(chr16:84134463-85705611) | copy number loss | not specified [RCV002052556] | Chr16:84134463..85705611 [GRCh37] Chr16:16q23.3-24.1 |
uncertain significance |
GRCh37/hg19 16q11.2-24.3(chr16:46503968-90155062)x3 | copy number gain | not provided [RCV002221458] | Chr16:46503968..90155062 [GRCh37] Chr16:16q11.2-24.3 |
pathogenic |
GRCh37/hg19 16q22.2-24.3(chr16:71641395-90161959)x3 | copy number gain | Syndromic anorectal malformation [RCV002286607] | Chr16:71641395..90161959 [GRCh37] Chr16:16q22.2-24.3 |
likely pathogenic |
NM_198491.3(CIBAR2):c.209G>A (p.Gly70Asp) | single nucleotide variant | not specified [RCV004280346] | Chr16:85110272 [GRCh38] Chr16:85143878 [GRCh37] Chr16:16q24.1 |
likely benign |
NM_198491.3(CIBAR2):c.304G>A (p.Ala102Thr) | single nucleotide variant | not specified [RCV004274546] | Chr16:85108051 [GRCh38] Chr16:85141657 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.757A>G (p.Thr253Ala) | single nucleotide variant | not specified [RCV004264942] | Chr16:85099343 [GRCh38] Chr16:85132949 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.671A>T (p.Gln224Leu) | single nucleotide variant | not specified [RCV004271983] | Chr16:85100221 [GRCh38] Chr16:85133827 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.625A>G (p.Lys209Glu) | single nucleotide variant | not specified [RCV004272202] | Chr16:85102240 [GRCh38] Chr16:85135846 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.571G>T (p.Val191Phe) | single nucleotide variant | not specified [RCV004350571] | Chr16:85102294 [GRCh38] Chr16:85135900 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.880G>A (p.Gly294Ser) | single nucleotide variant | not specified [RCV004347845] | Chr16:85099220 [GRCh38] Chr16:85132826 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.116C>T (p.Thr39Met) | single nucleotide variant | not specified [RCV004334655] | Chr16:85110365 [GRCh38] Chr16:85143971 [GRCh37] Chr16:16q24.1 |
uncertain significance |
GRCh37/hg19 16q24.1-24.2(chr16:84555718-87910245)x1 | copy number loss | not provided [RCV003483302] | Chr16:84555718..87910245 [GRCh37] Chr16:16q24.1-24.2 |
pathogenic |
NM_198491.3(CIBAR2):c.26G>T (p.Ser9Ile) | single nucleotide variant | not specified [RCV004441798] | Chr16:85110455 [GRCh38] Chr16:85144061 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.410C>T (p.Ser137Leu) | single nucleotide variant | not specified [RCV004441804] | Chr16:85107862 [GRCh38] Chr16:85141468 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.620T>G (p.Leu207Arg) | single nucleotide variant | not specified [RCV004441810] | Chr16:85102245 [GRCh38] Chr16:85135851 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.183C>A (p.Asn61Lys) | single nucleotide variant | not specified [RCV004441793] | Chr16:85110298 [GRCh38] Chr16:85143904 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.224T>C (p.Leu75Pro) | single nucleotide variant | not specified [RCV004441795] | Chr16:85110257 [GRCh38] Chr16:85143863 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.301G>A (p.Gly101Arg) | single nucleotide variant | not specified [RCV004441800] | Chr16:85108054 [GRCh38] Chr16:85141660 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.326C>G (p.Ala109Gly) | single nucleotide variant | not specified [RCV004441802] | Chr16:85107946 [GRCh38] Chr16:85141552 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.374T>G (p.Leu125Arg) | single nucleotide variant | not specified [RCV004441803] | Chr16:85107898 [GRCh38] Chr16:85141504 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.58A>G (p.Asn20Asp) | single nucleotide variant | not specified [RCV004441809] | Chr16:85110423 [GRCh38] Chr16:85144029 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.745G>A (p.Ala249Thr) | single nucleotide variant | not specified [RCV004441811] | Chr16:85100147 [GRCh38] Chr16:85133753 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.74T>A (p.Phe25Tyr) | single nucleotide variant | not specified [RCV004441812] | Chr16:85110407 [GRCh38] Chr16:85144013 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.781G>T (p.Ala261Ser) | single nucleotide variant | not specified [RCV004441814] | Chr16:85099319 [GRCh38] Chr16:85132925 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.908C>G (p.Ser303Cys) | single nucleotide variant | not specified [RCV004441816] | Chr16:85099192 [GRCh38] Chr16:85132798 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.110G>A (p.Arg37His) | single nucleotide variant | not specified [RCV004441791] | Chr16:85110371 [GRCh38] Chr16:85143977 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.122G>T (p.Arg41Leu) | single nucleotide variant | not specified [RCV004441792] | Chr16:85110359 [GRCh38] Chr16:85143965 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.272C>T (p.Thr91Ile) | single nucleotide variant | not specified [RCV004441799] | Chr16:85108083 [GRCh38] Chr16:85141689 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.539A>G (p.Lys180Arg) | single nucleotide variant | not specified [RCV004441807] | Chr16:85102326 [GRCh38] Chr16:85135932 [GRCh37] Chr16:16q24.1 |
likely benign |
NM_198491.3(CIBAR2):c.416A>C (p.Gln139Pro) | single nucleotide variant | not specified [RCV004441805] | Chr16:85107856 [GRCh38] Chr16:85141462 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.802C>A (p.Pro268Thr) | single nucleotide variant | not specified [RCV004441815] | Chr16:85099298 [GRCh38] Chr16:85132904 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.95T>G (p.Leu32Arg) | single nucleotide variant | not specified [RCV004441817] | Chr16:85110386 [GRCh38] Chr16:85143992 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.187G>A (p.Glu63Lys) | single nucleotide variant | not specified [RCV004441794] | Chr16:85110294 [GRCh38] Chr16:85143900 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.473G>A (p.Arg158His) | single nucleotide variant | not specified [RCV004441806] | Chr16:85105391 [GRCh38] Chr16:85138997 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.562A>G (p.Ile188Val) | single nucleotide variant | not specified [RCV004441808] | Chr16:85102303 [GRCh38] Chr16:85135909 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.184C>T (p.Pro62Ser) | single nucleotide variant | CIBAR2-related condition [RCV003946824] | Chr16:85110297 [GRCh38] Chr16:85143903 [GRCh37] Chr16:16q24.1 |
likely benign |
NM_198491.3(CIBAR2):c.713C>G (p.Thr238Ser) | single nucleotide variant | CIBAR2-related condition [RCV003921859] | Chr16:85100179 [GRCh38] Chr16:85133785 [GRCh37] Chr16:16q24.1 |
benign |
NM_198491.3(CIBAR2):c.736C>T (p.Gln246Ter) | single nucleotide variant | CIBAR2-related condition [RCV003932179] | Chr16:85100156 [GRCh38] Chr16:85133762 [GRCh37] Chr16:16q24.1 |
likely benign |
NM_198491.3(CIBAR2):c.633C>G (p.Asp211Glu) | single nucleotide variant | CIBAR2-related condition [RCV003927027] | Chr16:85102232 [GRCh38] Chr16:85135838 [GRCh37] Chr16:16q24.1 |
likely benign |
NM_198491.3(CIBAR2):c.163G>A (p.Asp55Asn) | single nucleotide variant | CIBAR2-related condition [RCV003941913] | Chr16:85110318 [GRCh38] Chr16:85143924 [GRCh37] Chr16:16q24.1 |
likely benign |
NM_198491.3(CIBAR2):c.10G>A (p.Val4Ile) | single nucleotide variant | not specified [RCV004441790] | Chr16:85112343 [GRCh38] Chr16:85145949 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.263G>A (p.Arg88Lys) | single nucleotide variant | not specified [RCV004441796] | Chr16:85108092 [GRCh38] Chr16:85141698 [GRCh37] Chr16:16q24.1 |
uncertain significance |
NM_198491.3(CIBAR2):c.323G>A (p.Arg108Gln) | single nucleotide variant | not specified [RCV004441801] | Chr16:85108032 [GRCh38] Chr16:85141638 [GRCh37] Chr16:16q24.1 |
uncertain significance |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | adipose tissue | appendage | |
High | |||||||||||||||
Medium | 1 | 240 | 5 | 368 | 1 | 28 | 199 | ||||||||
Low | 134 | 33 | 137 | 71 | 338 | 16 | 53 | 10 | 894 | 38 | 458 | 430 | 55 | 28 | 12 |
Below cutoff | 1341 | 1492 | 816 | 298 | 723 | 201 | 2297 | 852 | 1610 | 175 | 670 | 638 | 100 | 865 | 1345 |
RefSeq Acc Id: | ENST00000539556 ⟹ ENSP00000443411 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000618669 ⟹ ENSP00000478373 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000629253 ⟹ ENSP00000487117 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001366920 ⟹ NP_001353849 | ||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
||||||||||||
Sequence: |
RefSeq Acc Id: | NM_198491 ⟹ NP_940893 | ||||||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | XM_011523063 ⟹ XP_011521365 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_017023198 ⟹ XP_016878687 | ||||||||
Type: | CODING | ||||||||
Position: |
|
||||||||
Sequence: |
RefSeq Acc Id: | XM_054380215 ⟹ XP_054236190 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_054380216 ⟹ XP_054236191 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NP_940893 ⟸ NM_198491 |
- Peptide Label: | isoform 1 |
- UniProtKB: | A0A0D9SG36 (UniProtKB/Swiss-Prot), Q6ZTR7 (UniProtKB/Swiss-Prot), A0A1X7SC74 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | XP_011521365 ⟸ XM_011523063 |
- Peptide Label: | isoform X1 |
- UniProtKB: | A0A0D9SG36 (UniProtKB/Swiss-Prot), Q6ZTR7 (UniProtKB/Swiss-Prot), A0A1X7SC74 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | XP_016878687 ⟸ XM_017023198 |
- Peptide Label: | isoform X2 |
- UniProtKB: | Q6ZTR7 (UniProtKB/Swiss-Prot), A0A0D9SG36 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | NP_001353849 ⟸ NM_001366920 |
- Peptide Label: | isoform 2 |
- UniProtKB: | Q6ZTR7 (UniProtKB/Swiss-Prot), A0A0D9SG36 (UniProtKB/Swiss-Prot) |
RefSeq Acc Id: | ENSP00000487117 ⟸ ENST00000629253 |
RefSeq Acc Id: | ENSP00000443411 ⟸ ENST00000539556 |
RefSeq Acc Id: | ENSP00000478373 ⟸ ENST00000618669 |
RefSeq Acc Id: | XP_054236191 ⟸ XM_054380216 |
- Peptide Label: | isoform X2 |
RefSeq Acc Id: | XP_054236190 ⟸ XM_054380215 |
- Peptide Label: | isoform X1 |
- UniProtKB: | A0A1X7SC74 (UniProtKB/TrEMBL) |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q6ZTR7-F1-model_v2 | AlphaFold | Q6ZTR7 | 1-304 | view protein structure |
RGD ID: | 7233039 | ||||||||
Promoter ID: | EPDNEW_H22265 | ||||||||
Type: | initiation region | ||||||||
Name: | FAM92B_1 | ||||||||
Description: | family with sequence similarity 92 member B | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:24781 | AgrOrtholog |
COSMIC | CIBAR2 | COSMIC |
Ensembl Genes | ENSG00000153789 | Ensembl, ENTREZGENE, UniProtKB/TrEMBL |
Ensembl Transcript | ENST00000539556 | ENTREZGENE |
ENST00000539556.6 | UniProtKB/TrEMBL | |
ENST00000618669.3 | UniProtKB/TrEMBL | |
Gene3D-CATH | 1.20.1270.60 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
GTEx | ENSG00000153789 | GTEx |
HGNC ID | HGNC:24781 | ENTREZGENE |
Human Proteome Map | CIBAR2 | Human Proteome Map |
InterPro | AH/BAR_dom_sf | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
BAR_FAM92 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
FAM92 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
KEGG Report | hsa:339145 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
NCBI Gene | 339145 | ENTREZGENE |
OMIM | 617274 | OMIM |
PANTHER | CBY1-INTERACTING BAR DOMAIN-CONTAINING PROTEIN 2 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PTHR21223 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | FAM92 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PharmGKB | PA142671826 | PharmGKB |
Superfamily-SCOP | SSF103657 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
UniProt | A0A087WU51_HUMAN | UniProtKB/TrEMBL |
A0A0D9SG36 | ENTREZGENE | |
A0A1X7SC74 | ENTREZGENE, UniProtKB/TrEMBL | |
FA92B_HUMAN | UniProtKB/Swiss-Prot, ENTREZGENE | |
UniProt Secondary | A0A0D9SG36 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2019-12-25 | CIBAR2 | CBY1 interacting BAR domain containing 2 | FAM92B | family with sequence similarity 92 member B | Symbol and/or name change | 5135510 | APPROVED |
2015-11-24 | FAM92B | family with sequence similarity 92 member B | family with sequence similarity 92, member B | Symbol and/or name change | 5135510 | APPROVED |